CVS Health Inc.,has reduced its shares buy back Offer from $6 Billion to $5 Billion.
The Step is taken to sustain the Debt/EBITDA level under 3.2 after the acquisitions of Omnicare and Target’s pharmacy businesses close.
View the full release here.
CVS Health Inc.,has reduced its shares buy back Offer from $6 Billion to $5 Billion.
The Step is taken to sustain the Debt/EBITDA level under 3.2 after the acquisitions of Omnicare and Target’s pharmacy businesses close.
View the full release here.